Hepatitis B virus-associated intrahepatic cholangiocarcinoma and hepatocellular carcinoma may hold common disease process for carcinogenesis

European Journal of Cancer

Volumn 46, Issue 6, 2010, Pages 1056-1061

  Zhou, HuaBang ^a   Wang, Hui ^a   Zhou, DongXun ^a   Wang, Hao ^a   Wang, Qing ^a   Zou, ShanShan ^a   Tu, QianQian ^a   Wu, MengChao ^a   Hu, HePing ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Hepatic progenitor cells; Hepatitis B virus; Hepatocellular carcinoma; Intrahepatic cholangiocarcinoma

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CA 19-9 ANTIGEN; GAMMA GLUTAMYLTRANSFERASE; HEPATITIS B SURFACE ANTIGEN;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BILE DUCT STONE; CANCER INVASION; CANCER RISK; CASE CONTROL STUDY; CELL DIFFERENTIATION; CHINA; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GROUPS BY AGE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCHISTOSOMIASIS; SEX DIFFERENCE; VIRUS CARCINOGENESIS;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CELL TRANSFORMATION, NEOPLASTIC; CHINA; CHOLANGIOCARCINOMA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 77949487850     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2010.02.005     Document Type: Article

References (26)

1. Llovet J.M., and Bruix J. Novel advancements in the management of hepatocellular carcinoma in 2008. J Hepatol 48 Suppl. (2008) S20-S37
2. Watanapa P., and Watanapa W.B. Liver fluke-associated cholangiocarcinoma. Br J Surg 89 (2002) 962-970
3. Hughes N.R., Pairojkul C., Royce S.G., Clouston A., and Bhathal P.S. Liver fluke-associated and sporadic cholangiocarcinoma: an immunohistochemical study of bile duct, peribiliary gland and tumour cell phenotypes. J Clin Pathol 59 (2006) 1073-1078
4. Chalasani N., Baluyut A., Ismail A., et al. Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study. Hepatology 31 (2000) 247-248
5. Shaib Y., and El-Serag H.B. The epidemiology of cholangiocarcinoma. Semin Liver Dis 24 (2004) 115-125
6. Shaib Y.H., El-Serag H.B., Davila J.A., Morgan R., and McGlynn K.A. Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology 128 (2005) 620-626
7. Shaib Y.H., El-Serag H.B., Nooka A.K., et al. Risk factors of intrahepatic cholangiocarcinoma and extrahepatic cholangiocarinoma: a hospital-based case-control study. Am J Gastroenterol 102 (2007) 1016-1021
8. Ben-Menachem T. Risk factors for cholangiocarcinoma. Eur J Gastroenterol Hepatol 19 8 (2007) 615-617
9. Blechacz B.R., and Gores G.J. Cholangiocarcinoma. Clin Liver dis 12 (2008) 131-150
10. Singh S.K., Hawkins C., Clarke I.D., et al. Identification of human brain tumour initiating cells. Nature 432 (2004) 396-401
11. Singh S.K., Clarke I.D., Terasaki M., et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 63 (2003) 5821-5828
12. Wilkens L., Bredt M., Flemming P., et al. Differentiation of multicentric origin from intra-organ metastatic spread of hepatocellular carcinomas by comparative genomic hybridization. J Pathol 192 (2000) 43-51
13. Blechacz B., and Gores G.J. Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology 48 (2008) 308-321
14. Lee C.H., Chang C.J., Lin Y.J., et al. Viral hepatitis-associated intrahepatic cholangiocarcinoma shares common disease processes with hepatocellular carcinoma. Br J cancer 100 (2009) 1765-1770
15. Wands J. Hepatocellular carcinoma and sex. N Engl J Med 357 (2007) 1974-1976
16. El-Serag H.B., and Rudolph K.L. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132 (2007) 2557-2576
17. Kuper H., Ye W., Broome U., et al. The risk of liver and bile duct cancer in patients with chronic viral hepatitis, alcoholism, or cirrhosis. Hepatology 34 (2001) 714-718
18. El-Serag H.B., Engels E.A., Landgren O., et al. Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: a population-based study of US veterans. Hepatology 49 (2009) 116-123
19. Gitlin D., Perricelli A., and Gitlin G.M. Synthesis of-fetoprotein by liver, yolk sac, and gastrointestinal tract of the human conceptus. Cancer Res 32 (1972) 979-982
20. Bruce M.G., Bruden D., McMahon B.J., et al. Clinical significance of elevated alpha-fetoprotein in Alaskan Native patients with chronic hepatitis C. J Viral Hepat 15 (2008) 179-187
21. Murugavel K.G., Mathews S., Jayanthi V., et al. Alpha-fetoprotein as a tumour marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies. Int J Infect Dis 12 (2008) e71-e76
22. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., and Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100 (2003) 3983-3988
23. Ishikawa K., Sasaki A., Haraguchi N., Yoshikawa Y., and Mori M. A vase of an α-fetoprotein-producing intrahepatic cholangiocarcinoma suggests probable cancer stem cell origin. Oncologist 12 (2007) 320-324
24. Dabeva M.D., and Shafritz D.A. Activation, proliferation, and differentiation of progenitor cells into hepatocytes in the d-galactosamine model of liver regeneration. Am J Pathol 143 (1993) 1606-1620
25. Shiojiri N., Lemire J.M., and Fausto N. Cell lineage and oval cell progenitors in rat liver development. Cancer Res 51 (1991) 2611-2620
26. Shirabe K., Shimada M., Harimoto N., et al. Intrahepatic cholangiocarcinoma: its mode of spreading and therapeutic modalities. Surgery 131 (2002) S159-S164